Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04474743
Other study ID # A 2018-0129
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 2, 2018
Est. completion date September 13, 2021

Study information

Verified date November 2021
Source University Medicine Greifswald
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Malnutrition and muscle wasting are common consequences of life-threatening, chronic diseases of the gastrointestinal tract. Such diseases include liver cirrhosis, chronic pancreatitis and short bowel syndrome. Malnutrition and muscle wasting increase the risk of complications, reduce the life expectancy and impair the quality of life. The development of malnutrition and muscle wasting is different, as is the diagnosis and nutritional treatment. There are also different mechanisms of origin for the underlying diseases. The aim of the study is to compare data related to nutrition and physical condition of patients with liver cirrhosis, chronic pancreatitis and short bowel syndrome. Malnutrition and muscle wasting within the specific diseases will be characterized and possible correlations will be identified. For this, malnourished and non-malnourished patients of the different diseases are compared with controls patients with non-specific complaints of the gastrointestinal tract as well as with healthy study participants. Data on food intake, physical activity, body composition and body measurements as well as muscle strength and muscle function are recorded. Blood values as well as transport and barrier properties of the intestine will also be examined.


Description:

Malnutrition and sarcopenia are consequences of life-threatening gastroenterological diseases such as liver cirrhosis, chronic pancreatitis and short bowel syndrome and are associated with a poorer clinical outcome and a reduced quality of life. The diagnostic criteria of both conditions differ, as do the consequences for adequate nutritional therapy. Nevertheless, malnutrition and sarcopenia are often discussed in confusion in the literature. In addition, the underlying mechanisms of malnutrition and sarcopenia can differ in the various diseases. The aim of the study is to compare nutrition-associated parameters from patients with liver cirrhosis, chronic pancreatitis and short bowel syndrome, to characterize the disease-specific phenotype of malnutrition and sarcopenia of the examined diseases and to obtain information on mechanistic relationships. The pathophysiological understanding of the clinical settings as well as the development of malnutrition and sarcopenia is important for choosing specific nutritional therapies. For this, malnourished and non-malnourished patients of each examined disease are compared with controls from patients with non-specific, abdominal symptoms and healthy control subjects. Data on food intake, physical activity, body composition and anthropometry as well as muscle strength and muscle function are recorded. Clinical and chemical blood parameters, the plasma metabolome as well as transport and barrier proteins of the intestine are also examined.


Read more »

Study Design


Intervention

Other:
No intervention - cross-sectional observational only
No intervention - cross-sectional observational only

Locations

Country Name City State
Germany University Medicine Greifswald Greifswald
Germany University of Applied Sciences Neubrandenburg Neubrandenburg
Germany Univeristy Medicine Rostock Rostock

Sponsors (4)

Lead Sponsor Collaborator
University Medicine Greifswald Leibniz Institute for Farm Animal Biology (FBN), University Medical Center Rostock, University of Applied Sciences Neubrandenburg

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sarcopenia Descriptive and inferential determination of the prevalence of sarcopenia according to the European Working Group on Sarcopenia in Older People 2 criteria (EWGSOP2 criteria) in malnourished and non malnourished patients with liver cirrhosis, chronic pancreatitis or short bowel syndrome - as a total group and separated by type of disease Baseline
Primary Quantitative Food Intake Determination of quantitative food intake assessed by the German Health Interview and Examination Survey for Adults Food Frequency Questionnaire (DEGS-FFQ) in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Qualitative Food Intake Determination of qualitative food intake assessed by the Study of Health in Pomerania Food Frequency Questionnaire (SHIP-FFQ) in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Physical Activity Determination of physical activity assessed by the International Physical Activity Questionnaire (IPAQ) Short Form in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Body Weight Determination of body weight measured in kilograms in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Height Determination of height measured in meters in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Body Mass Index Determination of body mass index in kg/m^2 (calculated from the values obtained for body weight and height) in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Waist Circumference Determination of waist circumference measured in centimeters in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Hip Circumference Determination of hip circumference measured in centimeters in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Waist-to-Hip Ratio Determination of waist-to-hip ratio (calculated from the values obtained for waist and hip circumference) in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Upper Arm Circumference Determination of upper arm circumference measured in centimeters in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Triceps Skinfold Thickness Determination of triceps skinfold thickness measured in millimeters in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Fat Free Mass Determination of fat free mass measured by Bioelectrical Impedance Analysis (BIA) in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Skeletal Muscle Mass Determination of skeletal muscle mass measured by Bioelectrical Impedance Analysis (BIA) in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Fat Mass Determination of fat mass measured by Bioelectrical Impedance Analysis (BIA) in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Total Body Water Determination of total body water measured by Bioelectrical Impedance Analysis (BIA) in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Extracellular Water Determination of extracellular water measured by Bioelectrical Impedance Analysis (BIA) in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Phase Angle Determination of phase angle measured by Bioelectrical Impedance Analysis (BIA) in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Muscle Strength Determination of muscle strength measured by a handgrip strength dynamometer in comparison with non malnourished and non-sarcopenia patients and in comparison with healthy control subjects Baseline
Primary Hemoglobin Determination of hemoglobin level in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Hematocrit Determination of hematocrit level in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Mean Corpuscular Volume Determination of mean corpuscular volume in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Mean Corpuscular Hemoglobin Concentration Determination of mean corpuscular hemoglobin concentration in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Reticulocyte Count Determination of reticulocyte count in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Sodium Determination of plasma concentration of sodium in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Potassium Determination of plasma concentration of potassium in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Calcium Determination of plasma concentration of calcium in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Magnesium Determination of plasma concentration of magnesium in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Phosphate Determination of plasma concentration of phosphate in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Aspartate Transaminase Determination of plasma concentration of aspartate transferase in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Alanine Aminotransferase Determination of plasma concentration of alanine aminotransferase in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Gamma-glutamyl Transferase Determination of plasma concentration of gamma-glutamyl transferase in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Alkaline Phosphatase Determination of plasma concentration of alkaline phosphatase in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Bilirubin Determination of plasma concentration of bilirubin in comparison to control patients and in comparison to healthy control subjects Baseline
Primary C-reactive Protein Determination of plasma concentration of C-reactive protein in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Interleukin-1 Beta Determination of serum concentration of interleukin-1 beta in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Interleukin-6 Determination of plasma concentration of interleukin-6 in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Tumor Necrosis Factor Alpha Determination of serum concentration of tumor necrosis factor alpha in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Albumin Determination of plasma concentration of albumin in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Creatinine Determination of plasma concentration of creatinine in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Urea Determination of plasma concentration of urea in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Uric Acid Determination of plasma concentration of uric acid in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Glucose Determination of plasma concentration of glucose in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Glycated hemoglobin Determination of plasma concentration of glycated hemoglobin in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Insulin Determination of plasma concentration of insulin in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Total Cholesterol Determination of plasma concentration of total cholesterol in comparison to control patients and in comparison to healthy control subjects Baseline
Primary High-density Lipoprotein Cholesterol Determination of plasma concentration of high-density lipoprotein cholesterol in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Low-density Lipoprotein Cholesterol Determination of plasma concentration of low-density lipoprotein cholesterol in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Triglycerides Determination of plasma concentration of triglycerides in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Non-essential Fatty Acids Determination of plasma concentration of non-essential fatty acids in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Zinc Determination of serum concentration of zinc in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Iron Determination of plasma concentration of iron in comparison to control patients and in comparison to healthy control subjects Baseline
Primary Plasma Metabolome In a participants subgroup, investigations of the plasma metabolome in comparison with control patients and in comparison with healthy control subjects Baseline
Primary Intestinal Barrier Function Determination of the intestinal barrier function in a patient subgroup in comparison to control patients (using proximal small intestinal biopsies, qRT-PCR (Real Time Polymerase Chain Reaction) of different intestinal barrier markers) Baseline
Primary Expression of Intestinal Ion Transporters Determination of the expression of intestinal ion transporters in a patient subgroup in comparison to control patients (using proximal small intestinal biopsies, qRT-PCR (Real Time Polymerase Chain Reaction) of different intestinal transport markers) Baseline
Secondary Malnutrition-Sarcopenia Score Correlative, factorial or other presentation of the results including statistical-mathematical argumentation of the usefulness of a combined malnutrition-sarcopenia score (MaSa score) for practical application. Baseline
Secondary Validity of the Study of Health in Pomerania Food Frequency Questionnaire Determination of the validity of the Study of Health in Pomerania Food Frequency Questionnaire (SHIP-FFQ) by assessment of percent agreement with the German Health Interview and Examination Survey for Adults Food Frequency Questionnaire (DEGS-FFQ) Baseline
Secondary Factor Analysis of Phenotypes of Sarcopenia and Malnutrition Determination of parameters characterizing phenotypes of sarcopenia and malnutrition in the investigated gastroenterological disease (liver cirrhosis, chronic pancreatitis, short bowel syndrome) by factor analysis Baseline
See also
  Status Clinical Trial Phase
Completed NCT03112759 - Assessing the Utility of Cognitive Behavioral Therapy for Pain Control in Patients With Chronic Pancreatitis N/A
Enrolling by invitation NCT05410795 - Establishment and Verification of Pancreatic Volume Formula Based on Imaging
Active, not recruiting NCT02965898 - The Effect of Vitamin D Substitution on the Development of Chronic Pancreatitis N/A
Completed NCT02868047 - Establishing Standards for Normal Pancreatic EUS N/A
Completed NCT01452217 - Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy Volunteers Phase 1
Completed NCT00685087 - A Prospective Study of Natural History of Pancreatitis N/A
Completed NCT04949828 - Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms
Recruiting NCT06068426 - Incorporating Endoscopic Ultrasound and Elastography Towards Improving Outcomes of Pediatric Pancreatitis Management N/A
Active, not recruiting NCT05764629 - An Observational Study on Post-chronic Pancreatitis Diabetes Mellitus
Active, not recruiting NCT05042284 - Effect of Non-enteric Coated Enzymes Substitution on Pain in Patients With Chronic Pancreatitis N/A
Completed NCT03850977 - Is There an Association Between Chronic Pancreatitis and Pulmonary Function
Recruiting NCT05692596 - The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
Recruiting NCT06015945 - Role of Home-based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis N/A
Completed NCT04619511 - Risk Factors for Post-ESWL and Post-ERCP Pancreatitis
Completed NCT03283566 - Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT Phase 2
Recruiting NCT03434392 - QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing N/A
Completed NCT01430234 - Enzyme Suppletion in Exocrine Pancreatic Dysfunction Phase 4
Completed NCT01318369 - Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain Phase 2
Terminated NCT01442454 - Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis N/A
Completed NCT00755573 - Pain and Chronic Pancreatitis - Clinical End Experimental Studies Phase 2/Phase 3